LPAR1 antagonist 2 (example 76) is an LPAR1 antagonist with an average IC50 of 130 nM[1].

LPAR1 Human Pre-designed siRNA Set A contains three designed siRNAs for LPAR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lpar1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lpar1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPAR2 Human Pre-designed siRNA Set A contains three designed siRNAs for LPAR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lpar2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lpar2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPAR3 Human Pre-designed siRNA Set A contains three designed siRNAs for LPAR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lpar3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPAR3 Rat Pre-designed siRNA Set A contains three designed siRNAs for LPAR3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPAR4 Human Pre-designed siRNA Set A contains three designed siRNAs for LPAR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lpar4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lpar4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPAR5 Human Pre-designed siRNA Set A contains three designed siRNAs for LPAR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lpar5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lpar5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPAR6 Human Pre-designed siRNA Set A contains three designed siRNAs for LPAR6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lpar6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Lpar6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lpar6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPCAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for LPCAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPCAT2 Human Pre-designed siRNA Set A contains three designed siRNAs for LPCAT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPCAT4 Human Pre-designed siRNA Set A contains three designed siRNAs for LPCAT4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPGAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for LPGAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPIN1 Human Pre-designed siRNA Set A contains three designed siRNAs for LPIN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPIN2 Human Pre-designed siRNA Set A contains three designed siRNAs for LPIN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPIN3 Human Pre-designed siRNA Set A contains three designed siRNAs for LPIN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPL Human Pre-designed siRNA Set A contains three designed siRNAs for LPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPO Human Pre-designed siRNA Set A contains three designed siRNAs for LPO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPP Human Pre-designed siRNA Set A contains three designed siRNAs for LPP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LPPM-8 is a ligand of Med25 and an inhibitor of Med25 protein-protein interactions (PPIs). LPPM-8 engages Med25 through interaction with the H2 face of its Activator Interaction Domain and stabilizes full-length protein in the cellular proteome. LPPM-8 is an orthosteric inhibitor of H2-binding transcriptional activators (such as ATF6a). LPPM-8 can be used for studying Med25 […]

LPXN Human Pre-designed siRNA Set A contains three designed siRNAs for LPXN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LQ23 is a selective inhibitor for CDC2-like kinase 2 (CLK2) with an IC50 of 1.4 nM. LQ23 exhibits anti-inflammatory activity[1].

LRAT Human Pre-designed siRNA Set A contains three designed siRNAs for LRAT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRBA Human Pre-designed siRNA Set A contains three designed siRNAs for LRBA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRCH1 Human Pre-designed siRNA Set A contains three designed siRNAs for LRCH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRCH3 Human Pre-designed siRNA Set A contains three designed siRNAs for LRCH3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRCH4 Human Pre-designed siRNA Set A contains three designed siRNAs for LRCH4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRFN1 Human Pre-designed siRNA Set A contains three designed siRNAs for LRFN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRFN2 Human Pre-designed siRNA Set A contains three designed siRNAs for LRFN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRFN5 Human Pre-designed siRNA Set A contains three designed siRNAs for LRFN5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRG1 Human Pre-designed siRNA Set A contains three designed siRNAs for LRG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRGUK Human Pre-designed siRNA Set A contains three designed siRNAs for LRGUK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRIF1 Human Pre-designed siRNA Set A contains three designed siRNAs for LRIF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRIG1 Human Pre-designed siRNA Set A contains three designed siRNAs for LRIG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRIG2 Human Pre-designed siRNA Set A contains three designed siRNAs for LRIG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

LRIG3 Human Pre-designed siRNA Set A contains three designed siRNAs for LRIG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.